Pacira BioSciences, Inc. reported preliminary unaudited revenue results for the year ended December 31, 2024. The company reported preliminary unaudited total revenue of $701.0 million for the year ended December 31, 2024, compared with $675.0 million for the year ended December 31, 2023.